These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2232301)
1. [Protease activities in gastric and colon cancer tissues]. Chung SM; Kawai K; Chung HM; Kawamoto K; Tada M Nihon Shokakibyo Gakkai Zasshi; 1990 Aug; 87(8):1678-85. PubMed ID: 2232301 [TBL] [Abstract][Full Text] [Related]
2. Elevation of tissue cathepsin B and L activities in gastric cancer. Watanabe M; Higashi T; Hashimoto M; Tomoda I; Tominaga S; Hashimoto N; Morimoto S; Yamauchi Y; Nakatsukasa H; Kobayashi M Hepatogastroenterology; 1987 Jun; 34(3):120-2. PubMed ID: 3610018 [TBL] [Abstract][Full Text] [Related]
3. Impaired fibrinolysis and increased protease levels in gastric and duodenal mucosa of patients with active duodenal ulcer. Herszènyi L; Plebani M; Carraro P; De Paoli M; Cardin R; Di Mario F; Kusstatscher S; Naccarato R; Farinati F Am J Gastroenterol; 1997 May; 92(5):843-7. PubMed ID: 9149198 [TBL] [Abstract][Full Text] [Related]
4. Protease activities in gastric cancer tissues. Chung SM; Kawai K Clin Chim Acta; 1990 Aug; 189(2):205-10. PubMed ID: 2118842 [No Abstract] [Full Text] [Related]
5. Cathepsin B and L activities in gastric cancer tissue: correlation with histological findings. Watanabe M; Higashi T; Watanabe A; Osawa T; Sato Y; Kimura Y; Tominaga S; Hashimoto N; Yoshida Y; Morimoto S Biochem Med Metab Biol; 1989 Aug; 42(1):21-9. PubMed ID: 2775560 [TBL] [Abstract][Full Text] [Related]
6. Cysteine and serine proteases in gastric cancer. Plebani M; Herszènyi L; Cardin R; Roveroni G; Carraro P; Paoli MD; Rugge M; Grigioni WF; Nitti D; Naccarato R Cancer; 1995 Aug; 76(3):367-75. PubMed ID: 8625115 [TBL] [Abstract][Full Text] [Related]
7. Regulation of cathepsin B and L expression in vitro in gastric cancer tissues by egg cystatin. Saleh Y; Siewiński M; Kielan W; Ziółkowski P; Gryboś M; Rybka J J Exp Ther Oncol; 2003; 3(6):319-24. PubMed ID: 14678520 [TBL] [Abstract][Full Text] [Related]
9. Proteases as prognostic markers in cancer. Duffy MJ Clin Cancer Res; 1996 Apr; 2(4):613-8. PubMed ID: 9816210 [TBL] [Abstract][Full Text] [Related]
10. Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas. Shuja S; Sheahan K; Murnane MJ Int J Cancer; 1991 Sep; 49(3):341-6. PubMed ID: 1917131 [TBL] [Abstract][Full Text] [Related]
11. Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis. Farinati F; Herszényi L; Plebani M; Carraro P; De Paoli M; Cardin R; Roveroni G; Rugge M; Nitti D; Grigioni WF; D'Errico A; Naccarato R Carcinogenesis; 1996 Dec; 17(12):2581-7. PubMed ID: 9006092 [TBL] [Abstract][Full Text] [Related]
12. [Role and behavior of cathepsin B and cathepsin L in gastric cancer]. Herszényi L; Plebani M; Carraro P; De Paoli M; Roveroni G; Rugge M; Cardin R; Naccarato R; Farinati F Orv Hetil; 1995 Jun; 136(25):1315-8. PubMed ID: 7596589 [TBL] [Abstract][Full Text] [Related]
13. The state of differentiation of HT-29 colon carcinoma cells alters the secretion of cathepsin D and of plasminogen activator. Huet G; Zerimech F; Dieu MC; Hemon B; Grard G; Balduyck M; Janin A; Lafyatis R; Degand P Int J Cancer; 1994 Jun; 57(6):875-82. PubMed ID: 7911458 [TBL] [Abstract][Full Text] [Related]
14. [The role of cathepsins and the plasminogen activator/inhibitor system in colorectal cancer]. Herszényi L; Farinati F; Plebani M; István G; Sápi Z; Carraro P; De Paoli M; Naccarato R; Tulassay Z Orv Hetil; 1999 Aug; 140(33):1833-6. PubMed ID: 10489782 [TBL] [Abstract][Full Text] [Related]
15. The role of cysteine and serine proteases in colorectal carcinoma. Herszènyi L; Plebani M; Carraro P; De Paoli M; Roveroni G; Cardin R; Tulassay Z; Naccarato R; Farinati F Cancer; 1999 Oct; 86(7):1135-42. PubMed ID: 10506696 [TBL] [Abstract][Full Text] [Related]
16. Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinoma. Dohchin A; Suzuki JI; Seki H; Masutani M; Shiroto H; Kawakami Y Cancer; 2000 Aug; 89(3):482-7. PubMed ID: 10931446 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma. Häckel CG; Krueger S; Grote HJ; Oshiro Y; Hodges S; Johnston DA; Johnson ME; Roessner A; Ayala AG; Czerniak B Cancer; 2000 Sep; 89(5):995-1003. PubMed ID: 10964329 [TBL] [Abstract][Full Text] [Related]
18. Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L. Goretzki L; Schmitt M; Mann K; Calvete J; Chucholowski N; Kramer M; Günzler WA; Jänicke F; Graeff H FEBS Lett; 1992 Feb; 297(1-2):112-8. PubMed ID: 1551416 [TBL] [Abstract][Full Text] [Related]
19. Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters. Adenis A; Huet G; Zerimech F; Hecquet B; Balduyck M; Peyrat JP Cancer Lett; 1995 Sep; 96(2):267-75. PubMed ID: 7585467 [TBL] [Abstract][Full Text] [Related]
20. Cathepsins B, H and L in human breast carcinoma. Gabrijelcic D; Svetic B; Spaić D; Skrk J; Budihna M; Dolenc I; Popovic T; Cotic V; Turk V Eur J Clin Chem Clin Biochem; 1992 Feb; 30(2):69-74. PubMed ID: 1316176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]